Shilpa Medicare (SHILPAMED) Share Price rises 2.53% as stock trades at Rs 1,072.25
- October 1, 2026
- Posted by: Kunal Singla
- Category: News
Shilpa Medicare Share Price is higher today, with the stock last traded at Rs 1,072.25, up 2.53% from the previous close, and the company carrying a market capitalisation of Rs 20,665.17 crore. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. That makes the move a price action story first, rather than a news-led one. For readers tracking Shilpa Medicare Share Price Today, the key question is whether the move sits comfortably inside the broader valuation and sector picture. Univest data shows the stock opened near the previous close, moved to an intraday high of Rs 1,075.15 and a low of Rs 1,045.75, keeping the day range tight enough to analyse without leaning on speculation. The latest Univest figures also place Shilpa Medicare Share Price in a richer valuation pocket than many healthcare peers, which is where the fundamental context becomes important.
Shilpa Medicare Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,072.25 |
| Previous Close | Rs 1,045.75 |
| Today's Move | Rs 26.5 (+2.53%) |
| Open | Rs 1,047.95 |
| High | Rs 1,075.15 |
| Low | Rs 1,045.75 |
| Market Capitalisation | Rs 20,665.17 crore |
| Market Cap Category | Large Cap |
Shilpa Medicare Ltd. (SHILPAMED) rose to Rs 1,072.25 from the previous close of Rs 1,045.75, a move of Rs 26.5 or 2.53%. The stock opened at Rs 1,047.95, reached a high of Rs 1,075.15, recorded a low of Rs 1,045.75.
Shilpa Medicare Share Price rose 2.53% today, moving from the previous close of Rs 1,045.75 to a last traded price of Rs 1,072.25. The stock opened at Rs 1,047.95, touched a high of Rs 1,075.15 and a low of Rs 1,045.75, while market capitalisation stood at Rs 20,665.17 crore. This is a clear share price rise inside the current trading window, but it is still just one trading-day move, not a forecast. The fact pattern is simple: the stock is trading above the previous close and near the day’s upper end. According to latest Univest data, the event is confirmed and the move should be read as price action rather than a stated business catalyst. For investors following Shilpa Medicare Share Price Live, the next useful layer is fundamental analysis.
Shilpa Medicare Ltd. (SHILPAMED) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 20,665.17 crore |
| P/E Ratio | 68.79x |
| P/B Ratio | 7.61x |
| ROE | 9.82% |
| ROCE | 11.43% |
| EPS | Rs 15.2 |
| Book Value Per Share | Rs 137.34 |
| Dividend Yield | 0.06% |
Shilpa Medicare Ltd. (SHILPAMED) fundamental metrics show P/E 68.79x, P/B 7.61x, ROE 9.82%, ROCE 11.43%. Read together, these ratios describe the company’s position rather than a recommendation.
Shilpa Medicare Ltd. has a market capitalisation of Rs 20,665.17 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 68.79x, P/B at 7.61x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.82% and ROCE of 11.43%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 15.2, book value per share of Rs 137.34, dividend yield of 0.06%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.02x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 68.79x |
| Benchmark Median P/E | 32.02x |
| Benchmark Average P/E | 49.17x |
| Benchmark P/E Range | 3.4x to 688.17x |
| Company P/B Ratio | 7.61x |
| Benchmark Median P/B | 2.94x |
| Company ROE | 9.82% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 11.43% |
| Benchmark Median ROCE | 13.61% |
| Company Market Capitalisation | Rs 20,665.17 crore |
| Benchmark Median Market Cap | Rs 770.9 crore |
Shilpa Medicare Ltd. (SHILPAMED) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Shilpa Medicare Ltd. (SHILPAMED) has a P/E ratio of 68.79x, which is above the benchmark median of 32.02x, a difference of +114.83%. The P/E comparison frames valuation; it is not a signal to buy or sell.
Shilpa Medicare Ltd. (SHILPAMED) has a ROE of 9.82%, which is below the benchmark median of 11.7%, a difference of -16.07%. Shilpa Medicare Ltd. (SHILPAMED) has a ROCE of 11.43%, which is below the benchmark median of 13.61%, a difference of -16.02%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,46,276.3 | 36.1 | 5.05 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,51,531.48 | 84.24 | 13.95 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,86,956.51 | 83.74 | 20.35 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,19,221.66 | 25.71 | 4.3 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,11,728.51 | 32.36 | 3.1 | 11.83 | 16 |
Shilpa Medicare Ltd. (SHILPAMED) has a P/E ratio of 68.79x compared with the displayed peer median of 36.1x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 9.82% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 11.43% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Shilpa Medicare Ltd. (SHILPAMED) has a market capitalisation of Rs 20,665.17 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Shilpa Medicare
- Shilpa Medicare Share Price is rising today, with the stock trading above the previous close and near the day’s high.
- The latest Univest figures show a P/E of 68.79 and P/B of 7.61, which keep valuation in focus.
- ROE of 9.82% and ROCE of 11.43% place the current return profile below the same-industry median.
- Shilpa Medicare Share Price is being compared with healthcare peers that have very different valuation and return profiles.
- The market capitalisation of Rs 20,665.17 crore keeps Shilpa Medicare Share Price within a large listed-company framework.
About Shilpa Medicare
Shilpa Medicare Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is tracked by investors through Shilpa Medicare Share Price because it is part of a broader listed pharmaceutical universe where valuation, earnings power and return ratios matter. Based on the latest Univest figures, the company’s public-market profile is best read through its market capitalisation, earnings multiple, book multiple and capital efficiency metrics rather than through price alone.
Shilpa Medicare Share Price also matters because the company is assessed against a large same-industry set of 199 businesses. That means the stock is not viewed in isolation: it sits within a competitive pharmaceutical group where peers such as Sun Pharmaceutical Industries Ltd., Divi’s Laboratories Ltd., Torrent Pharmaceuticals Ltd., Zydus Lifesciences Ltd. and Cipla Ltd. provide the relevant comparison frame. For readers scanning Shilpa Medicare Stock News, this is a business where valuation and sector positioning are part of the daily story.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Shilpa Medicare Share Price rising today?
Ans. According to latest Univest data, Shilpa Medicare Share Price is up 2.53% today, but no company-specific catalyst is established. The move is confirmed through price action, open, high, low and previous close levels.
What is Shilpa Medicare Share Price today?
Ans. Shilpa Medicare Share Price is Rs 1,072.25. It traded above the previous close of Rs 1,045.75 and moved within an intraday range between Rs 1,045.75 and Rs 1,075.15 during the current market session.
How much did Shilpa Medicare Share Price rise today?
Ans. Shilpa Medicare Share Price rose by Rs 26.50, which equals 2.53% from the previous close. The latest Univest figures also show that the stock opened at Rs 1,047.95 before moving higher.
What is Shilpa Medicare Share Price market cap?
Ans. Shilpa Medicare Share Price is associated with a market capitalisation of Rs 20,665.17 crore. That places the company in a large listed-company framework and helps investors place the move in a valuation context.
Is Shilpa Medicare Share Price expensive on valuation?
Ans. Shilpa Medicare Share Price trades at a P/E of 68.79 and a P/B of 7.61, both above the same-industry median and average. That makes the valuation richer than many healthcare comparables in the latest Univest figures.
How do Shilpa Medicare ROE and ROCE compare with peers?
Ans. Shilpa Medicare shows ROE of 9.82% and ROCE of 11.43%, which sit below the same-industry medians. Several peers, including Zydus Lifesciences and Lupin, display stronger return metrics in the peer set.
What does Shilpa Medicare EPS and book value show?
Ans. Shilpa Medicare EPS is Rs 15.2 and book value is Rs 137.34. EPS reflects earnings attributable to each share, while book value shows accounting net worth per share, both useful in Shilpa Medicare Share Price analysis.
Should investors track Shilpa Medicare Share Price on Univest?
Ans. Yes. Shilpa Medicare Share Price can be tracked on Univest for live price, valuation ratios, 52-week levels and peer comparison. That gives a cleaner view of Shilpa Medicare Share Price Today and its market context.
Track Shilpa Medicare Share Price on Univest
Use Shilpa Medicare Ltd. (SHILPAMED) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors tracking Shilpa Medicare Share Price can use Univest to review the live share price, market capitalisation, valuation ratios, 52-week levels and company-level market insights in one place. Shilpa Medicare Share Price Today can be monitored alongside sector context, fundamental ratios and peer comparisons, which helps readers place each new move in a wider framework. Univest keeps the focus on verified price action and core business metrics, making Shilpa Medicare Share Price easier to follow as a market story rather than a headline-only move.
